Pharma-packaging firm based in Mumbai, Kaisha Packaging has successfully provided over 2 billion doses worth of flip-top aluminium seals used for packaging COVID-19 vaccines.

The seal is used as a closure for injection vials during the vaccination drive and is as such an essential part of the vaccine package ensuring tamper-proof delivery.  

Not only did KAISHA Packaging successfully manage this challenge, but it also expanded its capacity by over 450 million pieces to reach the overall capacity of 1.2 billion pieces per annum over the past year. 

Rishad Dadachanji, Director, Kaisha Group of Companies, shared, “Under the current circumstances of ambiguity around the COVID-19 pandemic, Kaisha is well-prepared to rise to any supply challenges.” 

The company is part of the larger Dadachanji Group, headquartered in Mumbai, India. It is a diversified group with business interests that include pharmaceuticals and biotechnology, primary and secondary packaging, medical devices, machine building, automation and robotics. The group previously also owned a part of the Indo-German Venture SCHOTT-Kaisha, which is the largest supplier of vaccine vials in the country.